MOLN

Molecular Partners AG - ADR

4.25

USD

MOLN Earnings Reports

Positive Surprise Ratio

MOLN beat 3 of 3 last estimates.

100%

Next Report

Date of Next Report

Mar 12, 2026

Estimate for Q4 25 (Revenue/ EPS)

-$0.34

Implied change from Q-- -- (Revenue/ EPS)

Implied change from Q4 24 (Revenue/ EPS)

+13.33%

Molecular Partners AG - ADR earnings per share and revenue

On --, MOLN reported earnings of -- USD per share (EPS) for -- --, -- the estimate of -- USD, resulting in a --% surprise. Revenue reached --, compared to an expected --, with a --% difference.

Looking ahead to Q4 25, 3 analysts forecast an EPS of -0.34 USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

Nurix Therapeutics, Inc. Common stock

Report Date

Jan 28, 2026 For Q4 25

Estimate

-$0.88

Actual

-$0.82

Surprise

+7.66%

Regeneron Pharmaceuticals Inc

Report Date

Jan 30, 2026 For Q4 25

Estimate

$10.84

Actual

$11.44

Surprise

+5.52%

FAQ

What were Molecular Partners AG - ADR's earnings and revenue for the latest quarter Q-- --?

For Q-- --, Molecular Partners AG - ADR reported EPS of --, Inline estimates by --, and revenue of --, -- -- expectations.

How did the market react to Molecular Partners AG - ADR's Q-- -- earnings?

The stock price moved -- --, changed from -- before the earnings release to -- the day after.

When is Molecular Partners AG - ADR expected to report next?

The next earning report is scheduled for Mar 12, 2026.

What are the forecasts for Molecular Partners AG - ADR's next earnings report?

Based on 3 analysts, Molecular Partners AG - ADR is expected to report EPS of -$0.34 and revenue of -- for Q4 2025.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.